Pension  Credit changes and what it could mean for people with Parkinson's and their carers.

The media reports on a large-scale study that suggests the removal of the appendix may increase the risk of Parkinson's.

Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.

The STEADY-PD clinical trial has failed to show that isradipine is an effective treatment to slow or stop progression in early Parkinson's.

The government initiative to fast-track access to new treatments and services is being expanded, potentially shaving years off the time it takes for people with Parkinson's to benefit from innovations in research.

Research shows that problems with recycling in brain cells in Parkinson's are overcome by the malaria drug clioquinol.

News about a debate on Parkinson's services held in the Scottish Parliament

News about joint work with the Scottish Government to research exercise and impact it has on Parkinson's.

Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.